Swiss firm Novartis reveals plans to take over Slovenia's Lek pharmaceutical company, while the battle over the Union brewery goes on. You have reached a premium content area of TOL. To read this entire article please login if you are already a TOL subscriber. Not a subscriber? Subscribe today for access to: Full access to the website, including premium articles videos, country reports and searchable archives (containing over 25,000 articles). You can subscribe here to gain access to the entire website.